<DOC>
	<DOC>NCT02138461</DOC>
	<brief_summary>This study examines patient perceptions regarding the tolerability of two classes of glaucoma medication: bimatoprost and latanoprost.</brief_summary>
	<brief_title>Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops</brief_title>
	<detailed_description>Patients enrolled in this study completed a validated survey instrument (COMTOL) examining tolerability of topically applied ophthalmic medications that they are already taking in their regular course of care for glaucoma. The purpose of the study is to determine whether side effects and symptoms of the drugs already being taken cause problems with activities of daily living.</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<criteria>Patients with glaucoma taking either bimatoprost or latanoprost patients taking other medication or with other causes for ocular surface symptoms</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>glaucoma</keyword>
	<keyword>bimatoprost</keyword>
	<keyword>latanoprost</keyword>
	<keyword>tolerability</keyword>
</DOC>